The BioInsights Podcast
The BioInsights Podcast: discussing the challenges of translating novel biologics from bench to clinic to market.
The BioInsights Podcast
For the many and the few: bringing ASO therapies to both mainstream and nano-rare indications
•
BioInsights
•
Season 4
•
Episode 2
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
Roisin McGuigan, Commissioning Editor, Nucleic Acid Insights, speaks to Stanley Crooke, Chairman, Founder and CEO, n-Lorem, about his long career and pioneering role in the antisense oligonucleotide (ASO) space, how RNA-targeting therapies are set to enter the mainstream, and his latest focus: making personalized, free-for-life ASO therapies available to nano-rare patient populations.